Latest news
Work you can support right now!
Prepare for the Future
Currently, many low- and middle-income countries (LMICs) are almost entirely dependent on imports and donations of COVID and other vaccines, contributing to vaccine inequity.
If mRNA vaccine technology from Moderna, BioNTech and Pfizer were shared, manufacturers in low- and middle-income countries could produce vaccines for global pandemic preparedness, as well as diseases of concern such as HIV, TB and malaria.
Publications
Read, watch, share
Our Wishlist for 2022
2
min
Cabotegravir: What are we waiting for?
100 years of insulin
MSF International President appeals to governments blocking landmark COVID-19 proposal
COVID-19: No patents or profiteering in a pandemic
No monopolies - Access to COVID-19 treatment
Lives Over Profit: a Patient, a Doctor and a Lawyer Take Action
A Snapshot of the Access Campaign
Our work
Join the conversation
Today, @BioNTech_Group reported >€9 billion in revenue for the first half of 2022 – >€2 billion more than the same time period in 2021, mostly from #COVID vaccine sales. Despite major public funding for the vaccine, BioNTech has yet to #ShareTheTech with LMIC manufacturers.
03:44 - 08 Aug 2022
BREAKING NEWS FROM #AIDS2022 @ViiVHC and @MedsPatentPool just announced a new agreement to allow generic production of CAB-LA in 90 countries at #AIDS2022But important countries are missing... ➡️ ow.ly/MAjH30soVCE twitter.com/MSF_access/sta…
07:41 - 28 Jul 2022
The most effective medication for HIV prevention is out of reach for people at highest risk of infection.Pharma corporation @ViiVHC who has the monopoly on the drug, can do a lot to improve access now and help meet global targets to reduce HIV infections. msfaccess.org/cabotegravir-w…
10:01 - 27 Jul 2022
